Hartline Investment Corp’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Hartline Investment Corp's BMY Position: Q2 2024 in Review
Hartline Investment Corp sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 19,099 shares — an estimated $1.04M sold.
Hartline Investment Corp first reported a position in BMY in Q4 2019 and held it in 17 quarters. The position peaked at $5.02M in Q4 2019. 2,153 funds tracked by Wall St. Rank hold BMY as of Q2 2024.
- Hartline Investment Corp reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
- Hartline Investment Corp sold 19,099 Bristol-Myers Squibb shares in Q2 2024, an estimated $1.04M.
- Hartline Investment Corp first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 17 quarters.
- Hartline Investment Corp's Bristol-Myers Squibb position peaked at $5.02M in Q4 2019.
- 2,153 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.
Based on Hartline Investment Corp's 13F filing for Q2 2024, filed 9 Aug 2024.